Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
•
Primary Care
Is there any reason to stop mesalamine in a patient with UC undergoing breast/regional nodal radiation?
Answer from: Radiation Oncologist at Community Practice
I have run into this situation a few times and have not stopped mesalamine during breast radiation. Have not noticed any issues.
Sign in or Register to read more
11392
Related Questions
Do you recommend self-breast exams to your patients with history of breast cancer in addition to imaging surveillance?
What is your preferred method of surveillance after mastectomy?
Do you recommend Hyaluronic Acid Therapy for vaginal dryness in female patients post pelvic RT?
Would you offer ultra-hypofractionated accelerated partial breast re-irradiation using 5 fractions?
How do you advise patients on cardiotoxicity when they are expected to receive a low mean heart dose and low cardiac substructure doses with their radiation plan?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
Is there a role for prophylactic Trental and vitamin E in a patient at high risk for osteoradionecrosis?
How would you treat a patient with HER2 positive CNS only progression on fam-trastuzumab which had previously progressed on tucatinib/capecitabine/trastuzumab, and has failed both SRS and WBRT?
When treating early stage breast cancer with adjuvant RT, what risk factors would lead you to include the level 1 and 2 axilla in patients with pN0(i+) disease?
Would you offer partial breast radiation to a young breast cancer patient with BRCA 1 if all other criteria are met?